Use access key #2 to skip to page content.
$54.03 -0.27 (-0.50%)
8/20/2008 3:03 PM

Biogen Idec, Inc. (BIIB)

CAPS Rating:
****

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

View Ticker Page (BIIB)

Results 41 - 50 of 77 :   12345Next »

Recs

0

Avatar cuin103 (66.86) Submitted: 4/05/08 7:27 PM : Outperform Start Price: $64.00 BIIB Score: -8.20

Bio tech play that needs consolidation

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar SuperStocker1 (26.46) Submitted: 8/14/08 9:25 PM : Outperform Start Price: $54.86 BIIB Score: 0.25

Recovery breakout upwards

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar KingPortu (65.15) Submitted: 10/29/07 2:36 PM : Underperform Start Price: $74.07 BIIB Score: 10.04

Not much to look at. Negative earnings, neg FCF, balance sheet is mediocre... Biotech sucks lately. What happened?

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar WilliamCrook2003 (68.67) Submitted: 1/28/07 6:16 PM : Outperform Start Price: $47.43 BIIB Score: 23.84

PROFIT

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar mf2006 (33.52) Submitted: 1/23/07 9:37 PM : Outperform Start Price: $49.26 BIIB Score: 20.13

I think the oral multiple sclerosis, if it is approved, could be a blockbuster.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar dymwit (92.36) Submitted: 1/03/07 12:47 PM : Outperform Start Price: $49.98 BIIB Score: 18.64

year of biotech...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar CKinRichmond (24.94) Submitted: 12/01/06 12:32 AM : Underperform Start Price: $52.50 BIIB Score: -11.87

Democrats are gunning for drug-makers and oil companies.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar SoMch2Knw (51.65) Submitted: 11/26/06 3:08 PM : Outperform Start Price: $51.14 BIIB Score: 14.37

The FDA wasn't so nice this year and biotech took a beating, but the risk/reward from here looks better than the 'benchmark'.

Report this Post Replies: 1 | Reply | Permalink

Recs

0

Avatar chrisccarlson (77.60) Submitted: 11/03/06 10:13 PM : Outperform Start Price: $48.01 BIIB Score: 19.55

If you like biotech this is your bluechip

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar rowder (< 20) Submitted: 10/19/06 6:43 PM : Outperform Start Price: $45.89 BIIB Score: 24.19

Tysabi will carry them up.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners